Some but not all studies have reported reduced rates of stent thrombosis (ST) with everolimus-eluting stents (EES) compared with other drug-eluting stents (DES). All of these studies were insufficiently powered to reliably detect differences in ST. We therefore performed a meta-analysis of randomized controlled trials comparing the risk of 2-year definite ST between EES and other DES.
Palmerini T, Kirtane AJ, Serruys PW, Smits PC, Kedhi E, Kereiakes D, et al. (2012). Stent thrombosis with everolimus-eluting stents: meta-analysis of comparative randomized controlled trials. CIRCULATION. CARDIOVASCULAR INTERVENTIONS., 5(3), 357-364 [10.1161/CIRCINTERVENTIONS.111.967083].
Stent thrombosis with everolimus-eluting stents: meta-analysis of comparative randomized controlled trials.
SANGIORGI, DIEGO;BACCHI REGGIANI, MARIA LETIZIA;
2012
Abstract
Some but not all studies have reported reduced rates of stent thrombosis (ST) with everolimus-eluting stents (EES) compared with other drug-eluting stents (DES). All of these studies were insufficiently powered to reliably detect differences in ST. We therefore performed a meta-analysis of randomized controlled trials comparing the risk of 2-year definite ST between EES and other DES.I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
